Deoxycytidylate Deaminase and Thymine Catabolism in Mouse and Rat Hepatomas
Author Information
Author(s): P. Emmelot, J. F. Hampe, C. J. Bos, I. H. M. Reyers
Primary Institution: The Netherlands Cancer Institute
Hypothesis
Can the presence of deoxycytidylate deaminase in rat hepatomas serve as a marker for the cell origin of these tumors?
Conclusion
The study found that while mouse hepatomas lacked deoxycytidylate deaminase activity, rat hepatomas exhibited varying levels of this enzyme, but no correlation was established between histology and enzyme levels.
Supporting Evidence
- Mouse hepatomas showed no dCMP deaminase activity.
- One mouse hepatoma had half the thymine catabolic activity of normal mouse liver.
- Normal rat liver was twice as active in thymine catabolism compared to normal mouse liver.
- Rat hepatomas exhibited very little thymine catabolic activity.
Takeaway
The researchers looked at how certain enzymes behave in liver tumors from mice and rats, finding that mouse tumors didn't have a specific enzyme, while rat tumors showed different levels of it.
Methodology
Enzyme activities were studied in supernatants from mouse and rat hepatomas, with specific assays for deoxycytidylate deaminase and thymine catabolism.
Limitations
The study's findings may not apply universally to all tumor types due to the non-uniform enzymic properties observed.
Participant Demographics
Three mouse hepatomas and four rat hepatomas were studied.
Want to read the original?
Access the complete publication on the publisher's website